This compound is a phosphorylated, methylated guanosine derivative used as a pharmaceutical intermediate for RNA modification research. It features a methylated purine base and a phosphate group on the ribose sugar, with a net neutral charge.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 94889-79-9
[(2R,3S,4R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-4-hydroxy-3-methoxyoxolan-2-yl]methyl phosphono phosphate;N,N-diethylethanamine
pharmaceutical intermediate
N(1)-methylpseudouridine 5'-monophosphate
RNA modification intermediate
1-Benzyl-4-piperidone oxime
pharmaceutical intermediate
3-Benzoyl-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid, (4S,5R)-
Pharmaceutical intermediate for paclitaxel
1-(5-CHLOROPYRIDIN-2-YL)ETHAN-1-ONE
pharmaceutical intermediate
2,4-DIHYDROXYBENZALDEHYDE
Pharmaceutical intermediate and building block
7-methylguanosine 5'-(trihydrogen diphosphate)
Pharmaceutical intermediate for nucleotide analogs
[(2R,3R,4R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3-hydroxy-4-methoxyoxolan-2-yl]methyl hydrogen phosphate
FHSYAAQTDTXBME-IOSLPCCCSA-N
CN1C=[N+](C2=C1C(=O)NC(=N2)N)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)[O-])O)OC
—